BATS BZX Real-Time Price
As of 12:59pm ET
| +0.14 / +0.94%|
The 5 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 17.50. The median estimate represents a +33.07% increase from the last price of 15.03.
The current consensus among 5 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.